Rankings
▼
Calendar
CLDX FY 2021 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CLDX
Celldex Therapeutics, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
-37.3% YoY
Gross Profit
-$49M
-1046.2% margin
Operating Income
-$71M
-1531.8% margin
Net Income
-$71M
-1516.0% margin
EPS (Diluted)
$-1.64
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$62M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$445M
Total Liabilities
$25M
Stockholders' Equity
$419M
Cash & Equivalents
$39M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$7M
-37.3%
Gross Profit
-$49M
-$35M
-38.6%
Operating Income
-$71M
-$63M
-12.5%
Net Income
-$71M
-$60M
-18.0%
← Q4 2020
All Quarters
Q1 2021 →